Journal article icon

Journal article

Beyond daily dosing: clinical experience.

Abstract:

Osteoporosis has had a significant public health impact, with many sufferers experiencing fractures. Such fractures lead to increased disability, mortality and reduced quality of life, all of which raise healthcare costs. Oral bisphosphonates are associated with significant antifracture efficacy and have therefore become the mainstay of treatment for postmenopausal osteoporosis. Poor therapeutic adherence with daily bisphosphonates has been improved by the introduction of weekly regimens, alt...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1016/j.bone.2006.01.152

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Journal:
Bone
Volume:
38
Issue:
4 Suppl 1
Pages:
S13-S17
Publication date:
2006-04-05
DOI:
EISSN:
1873-2763
ISSN:
8756-3282
URN:
uuid:5348ddee-5d7b-4c4a-a829-8bf7a2aa37af
Source identifiers:
125629
Local pid:
pubs:125629

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP